Spero Therapeutics (SPRO) Interest & Investment Income (2017 - 2025)
Historic Interest & Investment Income for Spero Therapeutics (SPRO) over the last 9 years, with Q3 2025 value amounting to $532000.0.
- Spero Therapeutics' Interest & Investment Income fell 5499.15% to $532000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 3338.95%. This contributed to the annual value of $4.7 million for FY2024, which is 2026.92% up from last year.
- Per Spero Therapeutics' latest filing, its Interest & Investment Income stood at $532000.0 for Q3 2025, which was down 5499.15% from $740000.0 recorded in Q2 2025.
- In the past 5 years, Spero Therapeutics' Interest & Investment Income registered a high of $1.3 million during Q1 2024, and its lowest value of $72000.0 during Q1 2022.
- Moreover, its 5-year median value for Interest & Investment Income was $740000.0 (2025), whereas its average is $645315.8.
- As far as peak fluctuations go, Spero Therapeutics' Interest & Investment Income plummeted by 5864.98% in 2021, and later skyrocketed by 123750.0% in 2023.
- Over the past 5 years, Spero Therapeutics' Interest & Investment Income (Quarter) stood at $76000.0 in 2021, then skyrocketed by 840.79% to $715000.0 in 2022, then skyrocketed by 45.87% to $1.0 million in 2023, then dropped by 1.44% to $1.0 million in 2024, then crashed by 48.25% to $532000.0 in 2025.
- Its last three reported values are $532000.0 in Q3 2025, $740000.0 for Q2 2025, and $864000.0 during Q1 2025.